EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY 4.0

Lung cancer (internet‐based) Delphi ( LUCiD ): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer

Jessica Nash iD, Emily Stone iD, Shalini Vinod iD, Tracy Leong iD, Paul Dawkins, Rob G Stirling, Susan Harden, Alison Bolton, Annette McWilliams iD, Kenneth O'Byrne, Gavin M Wright, Vanessa N Brunelli und 5 weitere

Respirology · 2024

DOI: 10.1111/resp.14812 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Respirology, 2024. Verfasst von Jessica Nash und 16 weiteren Autor:innen. Beteiligte Einrichtung: Curtin Medical School, Curtin University, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Delphi Technique, Quality Indicators, Health Care, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Approximately 16,000 new cases of lung cancer are diagnosed each year in Australia and Aotearoa New Zealand, and it is the leading cause of cancer death in the region. Unwarranted variation in lung cancer care and outcomes has been described for many years, although clinical quality indicators to facilitate benchmarking across Australasia have not been established. The purpose of this study was to establish clinical quality indicators applicable to lung and other thoracic cancers across Australia and Aotearoa New Zealand.

Methods

Following a literature review, a modified three round eDelphi consensus process was completed between October 2022 and June 2023. Participants included clinicians from all relevant disciplines, patient advocates, researchers and other stakeholders, with representatives from all Australian states and territories and Aotearoa New Zealand. Consensus was set at a threshold of 70%, with the first two rounds conducted as online surveys, and the final round held as a hybrid in person and virtual consensus meeting.

Results

The literature review identified 422 international thoracic oncology indicators, and a total of 71 indicators were evaluated over the course of the Delphi consensus. Ultimately, 27 clinical quality indicators reached consensus, covering the continuum of thoracic oncologic care from diagnosis to first line treatment. Indicators benchmarking supportive care were poorly represented. Attendant numeric quality standards were developed to facilitate benchmarking.

Conclusion

Twenty‐seven clinical quality indicators relevant to thoracic oncology care in Australasia were developed. Real world implementation will now be explored utilizing a prospective dataset collected across Australia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Delphi TechniqueQuality Indicators, Health CareLung NeoplasmsHumansNew ZealandAustraliaAustralasiaInternetBenchmarkingThoracic Neoplasms

Stichwörter der Autor:innen

Delphi consensus processbest practicelung cancermesothelioma

Autor:innen und Institutionen

  • Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
  • Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Department of Thoracic Medicine and Lung Transplantation, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.
  • School of Clinical Medicine, St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • South West Sydney Clinical Campuses, University of New South Wales, Sydney, New South Wales, Australia.
  • Cancer Therapy Centre, Liverpool Hospital, Sydney, New South Wales, Australia.

ORCID-Profile: Jessica Nash, Emily Stone, Shalini Vinod, Tracy Leong, Annette McWilliams, Fraser Brims

Zitieren

APA

Nash, J., Stone, E., Vinod, S., Leong, T., Dawkins, P., Stirling, R. G., Harden, S., Bolton, A., McWilliams, A., O'Byrne, K., Wright, G. M., Brunelli, V. N., Guan, T., Philpot, S., Navani, N., Brims, F., & LUCAP investigator team (2024). Lung cancer (internet‐based) Delphi ( LUCiD ): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer. Respirology. https://doi.org/10.1111/resp.14812

Vancouver

Nash J, Stone E, Vinod S, Leong T, Dawkins P, Stirling RG, et al. Lung cancer (internet‐based) Delphi ( LUCiD ): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer. Respirology. 2024. doi:10.1111/resp.14812

BibTeX
@article{Nash2024,
  author = {Nash, Jessica and Stone, Emily and Vinod, Shalini and Leong, Tracy and Dawkins, Paul and Stirling, Rob G and Harden, Susan and Bolton, Alison and McWilliams, Annette and O'Byrne, Kenneth and Wright, Gavin M and Brunelli, Vanessa N and Guan, Tracey and Philpot, Shoni and Navani, Neal and Brims, Fraser and LUCAP investigator team, LUCAP investigator team},
  title = {Lung cancer (internet‐based) Delphi ( LUCiD ): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer},
  journal = {Respirology},
  year = {2024},
  doi = {10.1111/resp.14812}
}
Kostenlos starten →